At this time, a generic version of MoviPrep is not available. The patent for this medication is set to expire in September 2024, which is the earliest possible date that a generic version of the drug could become available. It is important to note that polyethylene glycol electrolyte solution is the "generic name" for MoviPrep, not a generic version of the drug.
MoviPrep® (polyethylene glycol electrolyte solution) is a prescription medication used to cleanse the bowel before a colonoscopy. This is known as colonoscopy preparation, or simply "bowel prep."
MoviPrep is made by Norgine, LTD, for Salix Pharmaceuticals, Inc. It is not available in generic form, as it is protected by a patent that prevents any generic MoviPrep from being sold in the United States.
The patent for MoviPrep is set to expire in September 2024. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for specific MoviPrep uses. Once MoviPrep goes off-patent, there may be several companies that manufacture a generic version of the drug.
No -- polyethylene glycol electrolyte solution is the active ingredient in MoviPrep (as well as in several other medications), not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.